FIELD: medicine.
SUBSTANCE: invention deals with application of trans-resveratrol nano-form as medication, possessing anti-proliferative properties with respect to hormone-dependent diseases. In particular, such diseases can be represented by: breast cancer, uterus and cervix cancer, fibromyomas, ovary cancer, endometrium cancer, endometriosis, adenomyosis, prostate adenoma, prostate cancer.
EFFECT: application of invention makes it possible to extend arsenal of medications for treatment of proliferative hormone-dependent diseases due to obtaining novel transport nano-form of trans-resveratrol.
2 cl, 4 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING SOLID MALIGNANT GROWTHS AND THEIR METASTASES | 2010 |
|
RU2437692C2 |
| COMPOSITIONS CONTAINING RESVERATROL PARTICLES; AND METHOD FOR MAKING THEREOF (VERSIONS) | 2008 |
|
RU2373926C1 |
| COSMETIC COMPOSITION | 2008 |
|
RU2356570C1 |
| PHARMACEUTICAL COMPOSITION BASED ON GREEN COFFEE BERRY EXTRACT, METHOD FOR MAKING AND APPLYING | 2008 |
|
RU2378003C1 |
| COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
| ANTI-TUMOUR PREPARATION | 2011 |
|
RU2451509C1 |
| METHOD OF COSMETIC AND AGE SKIN DEFECT TREATMENT (CORRECTION) AT COMBINED APPLICATION OF FRACTION PHOTOTHERMOLYSIS TECHNOLOGY WITH BIOACTIVE INGREDIENTS INDEPENDENTLY OF ADMINISTRATION METHOD | 2007 |
|
RU2370275C2 |
| MEANS FOR STIMULATING SYNTHESIS OF HEAT SHOCK PROTEIN HSP 70 IN HUMAN AND ANIMAL CELLS; BEAUTY PRODUCT FOR STIMULATION OF REPARATIVE PROCESSES; BEAUTY PRODUCT FOR REDUCTION OF SIDE EFFECTS OF AGGRESSIVE COSMETIC PROCEDURES; BIOLOGICALLY ACTIVE ADDITIVE; FOOD PRODUCT; METHOD OF REDUCTION OF SIDE EFFECTS OF AGGRESSIVE COSMETIC PROCEDURES | 2012 |
|
RU2495928C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF DISEASES ASSOCIATED HORMONAL IMBALANCE, INCLUDING RELATED TO P450 CYTOCHROME METABOLIC IMBALANCE | 2007 |
|
RU2377984C2 |
| N-[3-OXOLUP-20(29)-ENE-28-OIL]-2,2,6,6-TETRAMETHYLPIPERIDINE-4-YLAMINE WITH CYTOTOXIC ACTIVITY IN RESPECT OF HUMAN TUMOUR CELLS | 2017 |
|
RU2641900C1 |
